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PreviewsNevertheless, the role of snapin in regu-
lating late endosomal trafficking and lyso-
somal fusion could be related to the
function of BLOC-1 and novel forms of
HPS. The perinatal lethality of snapin-null
mice, which may be related to such
amultivalent role of snapin in coordinating
several membrane transport/fusion sys-
tems, has hampered elucidation of the
specific roles of snapin in vivo. Therefore,
it would be important to clarify the physi-
ological and pathological role of snapin
in regulating the late endosome-lysosome
pathway in vivo by using snapin-L99K
knockin mice.
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Vesicular glutamate transporters (VGLUTs) load glutamate into synaptic vesicles. In this issue of Neuron,
Juge et al. report that ketone bodies compete with chloride-dependent activation of VGLUTs, leading to
suppression of glutamate release and seizures. These findings provide a surprising explanation for the
efficacy of the ketogenic diet in controlling epilepsy.The functioning of the mammalian CNS
depends on a delicate balance between
excitatory and inhibitory synaptic activi-
ties. Glutamate is the major excitatory
neurotransmitter in the brain, and its re-
lease is tightly regulated. At a given syn-
apse, the amount of glutamate released
per action potential depends on factors
such as past firing patterns, activity of
neighboring synapses, retrograde sig-
naling, and second-messenger cascades.
Most commonly, the number of synaptic
vesicles undergoing exocytosis is regu-
lated, and a vast amount of studies have
addressed this mechanism of synaptic
plasticity. However, it is becoming ap-parent that transmitter output may also
be controlled by changing the transmitter
content of synaptic vesicles (for review
see Ahnert-Hilger et al., 2003; Edwards,
2007).
Loading of synaptic vesicles with gluta-
mate is mediated by a small family of
vesicular glutamate transporters termed
VGLUTs1–3 (Edwards, 2007). Transport
is driven by a proton electrochemical
gradient across the vesicle membrane,
which is generated by a vacuolar ATPase
(Edwards, 2007). In contrast to the well-
characterized Na+-dependent glutamate
transporters in the plasma membrane,
our knowledge about VGLUTs is laggingbehind because VGLUTs can only be
studied in vesicles that contain an active
protonpump,greatly limitingexperimental
flexibility. To deter researchers even
further, VGLUTs expressed in nonneuro-
nal cells display low activities, and once
incorporated in the plasma membrane
they ‘‘moonlight’’ as Na+-dependent
transporters for inorganic phosphate
(Aihara et al., 2000; Ni et al., 1994).
Since the early days of measuring
vesicular glutamate uptake (Disbrow
et al., 1982; Naito and Ueda, 1985), it is
known that uptake depends on chloride
ions at millimolar concentrations. How-
ever, it has not been easy to distinguish
Figure 1. Multiple Roles for Chloride Ions in VGLUT-Mediated Filling of Synaptic Vesicles
Left: synaptic vesicles possess an electrogenic proton pump (V-ATPase). The resulting inside-positive
membrane potential fuels glutamate transport. At high Cl concentrations, Cl ions enter the vesicle
and balance the charge of protons, thus generating a pH gradient and dissipating themembrane potential.
Under physiological conditions, the initial intravesicular Cl concentration is expected to be high, raising
the possibility that Cl leaves the vesicle in exchange for glutamate, either via a vesicular chloride channel
or directly via VGLUT.
Right: reconstitution of VGLUT into proteoliposomes as described by Juge et al. (2010). A transient inside
positive membrane potential is generated by creating an inwardly directed K+ diffusion potential, which
drives glutamate uptake. No Cl transport is observed. However, glutamate uptake depends on allosteric
activation by Cl of VGLUT at a DIDS-sensitive binding site. Acetoacetate (acac) competes with Cl
binding and prevents activation of VGLUT.
Neuron
Previewswhether chloride acts directly on the
transporter or whether it acts indirectly
by affecting the proton electrochemical
gradient. The V-ATPase transports H+
ions in an electrogenic manner, resulting
in a high, inside positive, membrane
potential (see Figure 1). Chloride serves
as counter-ion entering the vesicle via a
chloride channel, which allows for the
accumulation of protons and the genera-
tion of a pH gradient at the expense of
the membrane potential. Since glutamate
transport is primarily driven by the mem-
brane potential, uptake is reduced at
increasing chloride concentrations (May-
cox et al., 1988). Furthermore, chloride is
sequestered during vesicle endocytosis
under physiological conditions and may
serve as counter-ion in exchange for glu-
tamate, thusmaintaining osmotic balance
and charge neutrality during vesicle refill-
ing (see Figure 1). However, none of these
mechanisms explains the strong activa-
tion of glutamate transport by a few milli-
molar Cl, suggesting the presence of
an allosteric regulatory binding site.
Why should anyone except for a few
aficionados of vesicular transporters
care about the intricacies of VGLUT re-
gulation by chloride ions? After all, the
intracellular chloride concentration is
comfortably above the needs for VGLUTactivation. In this issue of Neuron, Juge
et al. (2010) give a surprising answer by
showing that the allosteric activation of
VGLUTs by anions may be modulated
by energy metabolites, which has major
relevance for the treatment of common
neurological diseases.
Juge and colleagues (2010) used
a classical approach for their investigation
of VGLUTs: they purified the transporter
and then incorporated it into artificial
membrane vesicles. To circumvent the
need for an electrogenic proton pump
as energy source, the authors generated
transient, inwardly directed K+ diffu-
sion potentials (Figure 1, right panel). In
this simplified system, VGLUT-mediated
transport can be studied without inter-
ference by other proteins such as fickle,
multisubunit proton ATPases (see Fig-
ure 1). The data are extraordinarily clean,
with a signal-to-noise that was beyond
our dreams two decades agowhen we re-
constituted glutamate and GABA uptake
from crude vesicle extracts using the
same technique (Hell et al., 1991). The
authors show that VGLUTs are allosteri-
cally activated by chloride ions in a highly
cooperative manner: no transport without
chloride, initial activation at 2 mM and
saturation at 5 mM chloride, respectively.
In search for inhibitors the authors notedNeuronthat the ketone bodies acetoacetate
and b-hydroxybutyrate, at concentrations
reached during physiological ketogenesis
(see below), directly compete with chlo-
ride-dependent activation of VGLUTs.
These findings parallel an earlier report
in which branched-chain a-keto acids
where shown to compete with chloride
activation of glutamate transport (Reis
et al., 2000). Furthermore, incubation of
cultured neurons with acetoacetate re-
versibly decreased depolarization-in-
duced glutamate release and reduced
theamplitudeofminiature excitatorypost-
synaptic potentials whereas miniature
inhibitory potentials were not affected.
These findings are exciting since acetoa-
cetate is well known for its anticonvulsant
activity (Hartman et al., 2007). To explore
this connection further, the authors
induced seizures in rats by local injection
of a K+-channel blocker and then
measured transmitter release. Indeed,
coinjection of acetoacetate suppressed
convulsions, and glutamate but not dopa-
mine release was significantly reduced.
Together, these findings provide an
unexpected molecular explanation for
the hitherto enigmatic efficacy of ketone
bodies in controlling epileptic seizures.
Ketone bodies are energy metabolites
derived from acetyl CoA that can substi-
tute for glucose in aerobic oxidation.
Under physiological conditions, ketone
body production is increased when glu-
cose and insulin levels are low, i.e., during
starvation or when the body derives its
energy primarily from breakdown of fat.
Unlike tissues such as liver and muscle,
the brain cannot oxidize fatty acids and
is thus dependent on ketone bodies pro-
duced by the liver. When the brain shifts
to burning ketone bodies at low glucose
conditions, the cytoplasmic concentra-
tion of ketone bodies increases, resulting
in an inhibition of VGLUTs by blocking
chloride binding and thus in a global
dampening of glutamatergic transmis-
sion. The model also explains why the
neuroprotective effects of a ketogenic
diet (rich in fat, low in proteins and carbo-
hydrates) are thwarted by the ingestion of
sweets (Hartman et al., 2007): carbohy-
drates immediately decrease circulating
ketone body levels, thus lifting the inhibi-
tion of VGLUTs and increasing synaptic
glutamate output. Certainly, VGLUTs are
now on the map as potential drug targets.68, October 7, 2010 ª2010 Elsevier Inc. 7
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PreviewsThe study shows in an exemplary
fashion that even moderate changes in
vesicular neurotransmitter levels may
have major consequences for brain func-
tion. There is still much to learn about
how transmitter content depends on
transporter activity and energy gradients,
how transport activity is controlled by
metabolic and signaling pathways, and
how ion and osmotic balance is main-
tained during vesicle filling. Despite the
exciting progress provided by this study,
the roles of chloride ions in glutamate
uptake are far from clear. For instance,
the authors show convincingly that
chloride is not transported by VGLUT,
which contrasts with a previous study
providing similarly compelling evidence
for chloride transport and chloride:glu-
tamate exchange by VGLUT (Schenck
et al., 2009). Furthermore, chloride de-
pendence of VGLUT appears to be regu-8 Neuron 68, October 7, 2010 ª2010 Elsevierlated by the trimeric GTPase Gao2 (Winter
et al., 2005), but the underlying molecular
mechanism is not known. I am sure that
clean biochemical approaches as in the
study of Juge et al. (2010) will be instru-
mental in providing answers to these
important questions.REFERENCES
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